Radiolabeling Research at Alfa Cytology: Applications in Radiopharmaceutical Development

Nov 19, 2026

Alfa Cytology focuses on radionuclide labeling, compound analysis, and preclinical studies, covering multiple stages of radiopharmaceutical development.

New York, United States, November 19, 2026 /MarketersMEDIA/ -- Radiolabeling is an important technical link in the development of radiopharmaceuticals and can be used for compound tracking, diagnostic imaging, and related pharmacological studies. However, completing the labeling is only part of the research process. Researchers also need to investigate the properties, stability, and biological behavior of the labeled compounds according to the project objectives to provide a basis for subsequent experiments. Alfa Cytology provides radiolabeling and related research services, including compound preparation, analysis, and preclinical studies.

The preparation of radiolabeled compounds involves the selection of labeling sites, optimization of synthesis routes, purification, and analysis of products. Specific plans need to be determined in combination with the characteristics of the compounds and the research purpose, and further research could also involve stability, pharmacokinetics, and biodistribution. Therefore, the research process not only needs to consider how to prepare the labeled compounds, but also needs to determine the corresponding analysis and evaluation methods according to the intended use.

After the preparation of the compounds, analytical studies help to further understand their properties and performance during the experiment. Alfa Cytology provides pharmacokinetic and pharmacodynamic (PK/PD) studies, biodistribution and dosimetry studies, and stability and shelf-life studies of radiolabeled compounds. Analytical methods also include high-performance liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry (LC-MS/MS), and gamma counting. Depending on the research objectives of different projects, these methods can be used to investigate the relevant characteristics of compounds and provide an experimental basis for subsequent pharmacological research and preclinical evaluation.

Radiolabeling protocols also need to be selected according to the intended research application. Alfa Cytology's services include radiolabeling for PET, SPECT, and other studies, as well as the labeling of small molecules, biomolecules, and related conjugates. These techniques can be used in molecular imaging, drug research, and studies related to targeted radiotherapy. The appropriate approach depends on the properties of the compounds and the objectives of the project.

In addition to radiolabeling services, Alfa Cytology also provides research and development services related to radionuclide-drug conjugates (RDCs). RDC research and development involves components such as radionuclides, chelators, linkers, and targeting molecules, and needs to be designed and evaluated in combination with different coupling types and research phases. The services listed on the official website include RDC design, payload development, linker design and synthesis, chelator screening and synthesis, coupling, characterization, and preclinical research, covering different types of radionuclide coupling schemes such as antibodies, peptides, small molecules, and siRNA.

Radiolabeling and RDC-related studies can be applied to diagnostic imaging, targeted radiotherapy, and drug discovery. The evaluation focus of different projects depends on the candidate compounds and their research objectives, and may involve aspects such as compound stability, biodistribution, pharmacokinetics, or dosimetry. Combining compound preparation with subsequent analysis and preclinical studies helps researchers structure experiments around specific R&D questions, rather than just completing the labeling as an endpoint.

About Alfa Cytology

Alfa Cytology focuses on cancer research and related R&D services, covering drug discovery, radiopharmaceutical research, and preclinical research. The company provides technical services across different stages of research and development, including radiolabeling, radionuclide-drug conjugate (RDC) development, and compound analysis, for research areas such as diagnostic imaging, targeted radiotherapy, and drug development.

Contact Info:
Name: Toya Davis
Email: Send Email
Organization: Alfa Cytology
Website: https://www.rdcthera.com

Release ID: 89210124

Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.

MORE NEWS
LG Display scraps $2.25 bil. OLED investment plan
Nov 19, 2026
LG Display scraps $2.25 bil. OLED investment plan

LG Display said Thursday it has scrapped its plan to invest 3 trillion won ($2.25 billion) in a production line for large organic light-emitting diode (OLED) panels in South Korea. The decision came seven years after the display panel maker under LG Group announced plans in 2019 to build a 10.5-generation OLED production line in Paju, north of Seoul. In 2023, the company extended the investment completion deadline by five years to 2028, citing the COVID-19 pandemic and global economic uncertainties. In a regulatory filing, LG Display attributed its latest decision to significant changes in "uncontrollable external conditions" and market dynamics, citing the pandemic, geopolitical conflicts, high inflation and elevated interest rates. The company also pointed to a prolonged downturn in the large OLED panel market amid slowing OLED TV demand and a slower-than-expected transition from liquid crystal displays (LCDs) to OLEDs.

Korea's largest game show G-STAR at crossroads as top studios look abroad
Nov 19, 2026
Korea's largest game show G-STAR at crossroads as top studios look abroad

Launched in 2005, G-STAR has been widely considered a barometer of South Korea's gaming industry, giving developers a stage to debut upcoming titles, and facilitating cross-border exchanges between local studios and overseas publishers. Despite ups and downs, including a complete cancellation during the COVID-19 pandemic, the annual event has maintained its reputation as South Korea's flagship game fair. After two decades, however, the event is now at a crossroads. Despite efforts to expand its scope into other sectors, such as webtoons and motor racing, major domestic game companies are turning away from the event and visitor numbers are declining. Three of the country's biggest game companies -- NC Corp., Netmarble Corp. and Nexon Games Co. -- were absent from this year's G-STAR, which kicked off its three-day run in the southeastern port city of Busan on Thursday. Nexon and NC served as the event's main sponsors in 2024 and 2025, respectively. It marked the first time the three game giants bypassed the event since 2021, when the country was reeling from the COVID-19 pandemic. Krafton In

Live updates: Crypto leaders talk policy at Hill event; Trump, Xi, Putin issue peace declaration
Nov 19, 2026
Live updates: Crypto leaders talk policy at Hill event; Trump, Xi, Putin issue peace declaration

A major cryptocurrency bill remains stalled in the Senate more than a year after clearing the House, with lawmakers facing mounting pressure to establish a federal regulatory framework for digital assets. The Clarity Act has faced hurdles ranging from partisan ethics concerns to disputes between traditional banks and the crypto industry over stablecoin rewards and...

Watch live: The Hill's Capitol Crypto Forum
Nov 19, 2026
Watch live: The Hill's Capitol Crypto Forum

A new generation of financial infrastructure is taking shape through the development of blockchain networks and dollar-backed tokens known as stablecoins. Central to this evolution is the Clarity Act — a comprehensive landmark bill that would create a U.S. regulatory framework for the cryptocurrency industry. While the House voted to advance the Digital Asset Market...

Alibaba’s AI bet paying off as cloud services drive 10% revenue jump
Nov 19, 2026
Alibaba’s AI bet paying off as cloud services drive 10% revenue jump

Alibaba Group Holding’s external recurring revenue tied to AI cloud and computing surged 67 per cent during the quarter ended September 30, lifting total revenue 10 per cent to a better-than-expected 271.5 billion yuan (US$40.5 billion) as the company doubles down on full-stack AI capabilities. The tech and e-commerce giant’s AI Cloud and Compute Services segment, comprising its cloud computing business and chip design unit T-Head, which filed for an initial public offering in Hong Kong in...

Policymakers view Anthropic's looming IPO with wary eye
Nov 19, 2026
Policymakers view Anthropic's looming IPO with wary eye

Lawmakers are watching Anthropic's stock market debut with a wary eye, as the AI giant prepares for a massive initial public offering (IPO) at a moment of upheaval and uncertainty for the industry. Anthropic is poised to make its public debut Thursday in what is widely expected to be one of the biggest IPOs of the year. But...

Some feared an AI attack. The real reason for tech outages is more complicated
Nov 19, 2026
Some feared an AI attack. The real reason for tech outages is more complicated

A string of technology outages across the country has the public quickly pointing fingers at artificial intelligence as fears swirl over a so-called "doomsday." Researchers and public officials are suggesting AI was a likely factor— but not in the way people initially suspected. After days of uncertainty over the outages, national security officials in the...

Johor’s data-centre future is being decided in Ohio and Washington
Nov 19, 2026
Johor’s data-centre future is being decided in Ohio and Washington

American voters spent this month’s midterms arguing about data centres: who pays for the power, who loses the water, and who gets a say. Southeast Asia, which has quietly become the overflow tank for the world’s compute, never got that argument. It got press statements. Worse, the two decisions that will shape Johor’s data-centre future […] The post Johor’s data-centre future is being decided in Ohio and Washington appeared first on e27.

After Megaspeed, Indonesia pays the compliance bill for Asia’s AI chip race
Nov 19, 2026
After Megaspeed, Indonesia pays the compliance bill for Asia’s AI chip race

For two years, Indonesia has pitched itself as the place where Asia’s AI workloads would live: a huge domestic digital market, surplus power and a government eager to cut ribbons on hyperscale campuses. Washington has just added a line to that brochure: terms and conditions apply. In a note published on Tuesday, Maybank Investment Bank […] The post After Megaspeed, Indonesia pays the compliance bill for Asia’s AI chip race appeared first on e27.

If nobody knows you, nobody owes you their trust: How founders can build it anyway
Nov 19, 2026
If nobody knows you, nobody owes you their trust: How founders can build it anyway

Here is an uncomfortable truth about business: If nobody knows you, nobody owes you their trust. An established company does not walk into a room carrying only its product. It carries years of reputation, relationships, customer references and a network built long before the current opportunity appeared. A founder starting out has none of that. […] The post If nobody knows you, nobody owes you their trust: How founders can build it anyway appeared first on e27.

Anthropic’s record US$81.3 billion IPO arms US AI giant for price war with Chinese rivals
Nov 19, 2026
Anthropic’s record US$81.3 billion IPO arms US AI giant for price war with Chinese rivals

Anthropic’s record-shattering US$81.3 billion initial public offering (IPO) is handing the US artificial intelligence powerhouse a massive war chest to wage a global price war, piling fresh valuation and monetisation pressure on lower-cost Chinese rivals, according to analysts. The San Francisco-based creator of the Claude chatbot priced its shares at US$83 apiece on Wednesday, above its marketed range of US$70 to US$78, giving the firm a market capitalisation of around US$1.5 trillion ahead of...

Your brand ranks on Google, so why doesn’t ChatGPT recommend it?
Nov 19, 2026
Your brand ranks on Google, so why doesn’t ChatGPT recommend it?

A business owner in Petaling Jaya asked me something recently that I keep coming back to. A customer told her she’d “asked ChatGPT for recommendations” and her company wasn’t on the list, even though she ranks on Google’s first page for her main keyword. She wanted to know what she’d done wrong. Probably nothing. But […] The post Your brand ranks on Google, so why doesn’t ChatGPT recommend it? appeared first on e27.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.